This study investigates the transcriptomic responses of salmon lice (L. salmonis) infecting salmon treated with emamectin benzoate (either 1x or 3x), ivermectin, or commercial feed controls
Overall design
Copepodid-staged larvae of L. salmonis were used to infect Atlantic salmon fed 1x or 3x emamectin benzoate, ivermectin, or commercial feed controls. Pre-adult I lice were collected from each group, pooled by treatment group and sex (pools of 6 lice) and stored at -80C for RNA extraction and microarray analyses. A total of 48 pools were used (n = 6 per condition except n = 5 for male controls and n = 7 for male 3xEMB)